Goldman Sachs Group Inc Cytokinetics Inc Call Options Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$51.22 - $60.16 $911,716 - $1.07 Million
-17,800 Reduced 27.26%
47,500 $2.51 Million
Q2 2024

Aug 13, 2024
BUY
$47.86 - $75.05 $2.26 Million - $3.55 Million
47,300 Added 262.78%
65,300 $3.54 Million
Q1 2024

May 15, 2024
SELL
$63.75 - $108.06 $11.7 Million - $19.9 Million
-184,100 Reduced 91.09%
18,000 $1.26 Million
Q4 2023

Feb 13, 2024
BUY
$26.88 - $83.49 $5.43 Million - $16.9 Million
202,100 New
202,100 $16.9 Million

Others Institutions Holding CYTK

# of Institutions
409
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.6B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email